Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM

NCT00969436 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

450

Enrollment

INDUSTRY

Sponsor class

Conditions

Varicella
Rubella
Mumps
Measles

Interventions

BIOLOGICAL: GSK Biological's investigational MMRV vaccine 208136
BIOLOGICAL: Priorix™
BIOLOGICAL: Varilrix™

Sponsor

GlaxoSmithKline